Skip to main content

Table 2 Toxicity profile between patients groups

From: The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

Clinical variables

LDH

LDH

LDH

LDH

Total

≤407 U/l

>407 U/l

Decreased

Increased

Patients

53 (%)

25 (%)

26

52

78

Any grade toxicity

Global

24 (45)

9 (36)

13 (50)

20 (38)

33

Rash

5 (9)

3 (12)

4 (15)

4 (8)

8

Hand-foot

9 (17)

4 (16)

7 (27)

6 (12)

13

Nausea/vomiting

3 (6)

2 (8)

1 (4)

4 (8)

5

Diarrhea

11 (21)

3 (12)

6 (23)

8 (15)

14

Fatigue

5 (9)

5 (20)

4 (15)

6 (12)

10

Liver dysfunction

0 (0)

2 (8)

1 (4)

1 (2)

2